All articles by Eoin Ryan

EC’s proposed pharma reforms spark industry discontent

This blog explores the key areas of concern for pharmaceutical companies and some of the potential implications of these reforms.

Inflationary storm clouds will continue to buffet global pharma industry in 2023

The pharma industry may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US.

New dawn for the EU’s joint procurement crisis response

The upcoming changes to the EU’s joint procurement rules will apply in instances of ‘serious cross-border threats to health’.

How horizon scanning can help predict the future for EU’s Alzheimer’s disease market

Aduhelm’s US launch has prompted a new look into what is in store for the Alzheimer’s disease market over the coming years.

Pharmaceutical and healthcare sectors jointly top global PMI ranking for first time

Industry hopes dashed after EU compromises to squeeze through cross border HTA agreement

Unlocking biomarker diagnostics in Europe and the win-win for the innovative oncology sector

EU countries make inroads in COVID-19 vaccination race even as supply concerns linger

Irish green credentials fail on pharmaceutical waste exports

Accuracy check: Norwegian health expenditure data